Dexcom G7 15 Day receives FDA clearance, offering adults with diabetes the longest lasting and most accurate continuous glucose monitoring system to date.
Compared with a historical cohort of patients hospitalized for influenza, those hospitalized for COVID-19 had a 45% higher post-acute type 2 diabetes risk during delta and a 56% higher risk during omicron.
Conexiant
Daily News
Stay up to date with the latest clinical headlines and other information tailored to your specialty.
Researchers highlight evidence-based lifestyle and pharmacologic strategies, including glycemic excursion minimization and tirzepatide, for early glycemic control in adults with type 2 diabetes.
New research reveals 25% tariffs on Canadian pharmaceuticals would impact critical medications, strain supply chains, and potentially increase costs—with 28 drugs having no alternative suppliers.